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ABSTRACT
Objective: This retrospective investigation describes the infectious morbidity of patients following
radical vulvectomy with or without inguinal lymph node dissection.
Methods: The charts of patients undergoing radical vulvectomy between January 1, 1986, and
September 1, 1989, were reviewed for age, weight, cancer type, tumor stage, operative procedure(s),
prophylactic antibiotic and its length of use, febrile morbidity, infection site, culture results, signifi-
cant medical history, and length ofuse and number of drains or catheters used.
Results: The study group was composed of 61 patients, 14 ofwhom underwent a radical vulvec-
tomy and 47 who also had inguinal lymph node dissection performed. Twenty-nine patients (48%)
had at least I postoperative infection. Five patients (8%) had 2 or more postoperative infections. The
site and incidence ofthe infections were as follows: urinary tract 23%, wound 23%, lymphocyst 3%,
lymphatics (lymphangitis) 5%, and bowel (pseudomembranous colitis) 3%. The most common
pathogens isolated from both urine and wound sites were Pseudomonas aeruginosa, enterococcus, and
Escherichia coli. A significant decrease in wound infection was demonstrated when separate inci-
sions were made for inguinal lymph node dissection (P <0.05). The mean number ofdays to onset of
postoperative infection for wound, urine, lymphatics, lymphocyst, and bowel were 11, 8, 57, 48, and
5, respectively.
Conclusions: We conclude that the clinical appearance of post-radical vulvectomy infections is
delayed when compared with other post-surgical wound infections. Second, utilizing separate in-
guinal surgical incisions may reduce infectious morbidity. Finally, tumor stage and type do not
necessarily increase the infectious morbidity ofradical vulvar surgery. (C) 1994 Wiley-Liss, Inc.
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nfectious morbidity/mortality in gynecologic on-
cology has not been the subject of extensive inves-
tigation. An understanding of the basis of these
infections requires an understanding of the multi-
ple infection risk factors in the host, those in the
extended radical surgical procedures, and factors
inherent in the tumor itself. 1,2
Host factors include 1)normal vaginal flora;
2) altered flora and organism virulence in malig-
nancy; 3) altered flora from previous use of antimi-
crobials including the induction of antimicrobial
resistance and superinfection;
3-8 4) general host de-
fense factors such as mucosal barriers, cellular and
humoral immunity, and normal and decreased neu-
trophil, lymphocyte, and macrophage function;
5) known surgical risk factors in women with ma-
lignancy such as older age, poor nutritional status
(weight loss, obesity), and concurrent disease such
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as diabetes, hypertension, and bacterial or viral
sexually transmitted disease; and 6) previous che-
motherapy and/or radiation therapy.
Risks derived from the radical surgical proce-
dure include 1)prolonged time of operation with
the increased dissection and tissue damage of the
extended "radical" procedure and presence ofblood
and exudate in the operative site and 2)anesthesia
risk.
1-12
The major risks arising from the tumor itself
are 1) preexisting subclinical infections in prolifer-
ating and necrotic malignancy and 2) possible im-
munosuppressive effects exerted by the tumor
itself.
13-23
In addition to the usual risks deriving from host
factors, from surgical procedures, and from the
tumor itself, invasive diagnostic techniques used
before surgery add to the risk from the possibility
of preexisting occult infection of the genital tissue
and possible introduction of nosocomial infection.
Invasive procedures such as cystoscopy, proctos-
copy, needle biopsy, and dilatation and curettage
are routine in the work-up of a patient with gyneco-
logic malignancy.
Finally, modern supportive procedures that add
to postoperative infection risk include ureteral cath-
eterization, percutaneous nephrostomy, central
venous catheterization, hyperalimentation, and use
ofJackson-Pratt drainage tubes, as well as urethral
catheterization, insertion of a nasogastric tube, and
placement of an intravenous line, all of which are
14,15
common in patients after surgery.
Of the gynecologic malignancies, the literature
is perhaps the most conspicuously lacking in infor-
mation relating to infectious complications associ-
ated with vulvar cancer. Although wound break-
down has been reported to be as high as 50% in
patients undergoing radical vulvectomy,
24 a de-
scription of the associated infectious morbidity has
not been reported. The purpose of this retrospec-
tive study is to document specific elements of infec-
tious morbidity in patients undergoing radical vul-
vectomy with or without inguinal lymph node dis-
section, namely, organisms encountered; site of in-
fection; sequence and time course of the appearance
of clinical infections; association with drains and
catheters; effect of tumor type and stage; and influ-
ence of surgical incisions. This study does not re-
place the need for prospective randomized trials to
evaluate prophylactic antibiotic use in these patients.
SUBJECTS AND METHODS
The charts of all patients operated on for vulvar
cancer at the University of Minnesota Women’s
Cancer Center between January 1, 1986, and Sep-
tember 1, 1989, were reviewed. Data retrieved
included the patient’s age, weight, cancer type, tu-
mor stage, operative procedure(s), prophylactic an-
tibiotic and its length of use, febrile morbidity,
infection site, culture results, significant medical
history, and length of use and numbero drains or
catheters. Patients receiving radiation or chemo-
therapy within 60 days of surgery were excluded
from the study. Those with a history of radiation or
vulvar surgery were also excluded.
The following criteria were used to retrospec-
tively define infectious morbidity: 1) febrile mor-
biditym2 oral temperatures, at least 4 h apart, of
38C or higher on a day beyond the 1st postopera-
tive day or an oral temperature of 38.3C or higher
within the 1st 24 h of the postoperative period;
2) wound infectiondistinct cellulitis (erythema,
induration, and tenderness at the margin of the
incision) and/or actual purulent drainage from the
incision (simple stitch abscess, seroma, and he-
matoma were not considered true wound infections);
3) infected lymphocystinduration, erythema,
and/or tenderness overlying a lymphocyst in a fe-
brile patient (with no other source of infection);
4) lymphangitisinduration, erythema, and ten-
derness extending down the lymphatics of the thigh
or leg (in the opinion of the primary physician);
5) urinary tract infection (UTI)urine culture ob-
tained by catheterization, demonstrating at least 102
uropathogens/ml of urine; 6) septicemiapositive
aerobic or anaerobic blood culture in a febrile pa-
tient; and 7)pseudomembranous colitismpositive
Clostridium diyficile toxin or culture in the stool of a
patient with diarrhea.
Comparisons between groups within the study
population were made by means of the uncorrected
chi-square test, the 2-tailed independent sample
t-test, and the 2-way analysis of variance test.
P < 0.05 was considered statistically significant.
RESULTS
The study group was composed of 61 patients, 14
of whom underwent radical vulvectomy alone and
47 of whom had radical vulvectomy with inguinal
lymph node dissection. Both same incision and sep-
arate incisions were utilized in inguinal lymph node
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TABLE I. Frequency of tumor type and stage in infected and noninfected patients
Tumor type Stage Noninfected Infected
Squamous cell carcinoma FIGO
II
III
Unknown
Total
Malignant melanoma Clark’s III
IV
Total
Paget’s disease FIGO IV
Adenocarcinoma of Bartholin’s gland FIGO II
III
Total
Basal cell carcinoma FIGO II
Grand totals
13
7
6
27
2
0
2
0
2
32
I0
I0
5
26
2
0
0
0
0
29
dissections. The type of incision made was depen-
dent on surgeon preference and prior training and
not on the extent of disease. No statistical difference
in mean age (67 years) or weight (69 kg) was noted
in the postoperative infected vs. noninfected group.
A frequency distribution oftumor type and stage
in both the infected and noninfected groups of pa-
tients is given in Table 1. A significant difference
in the frequency of infection with respect to tumor
type and stage was not discernible (P > 0.05).
Twenty-nine patients (48%) had at least post-
operative infection. Excluding UTIs, 17 patients
(28%) had at least postoperative infection. Five
patients (8%) had 2 or more postoperative infection
sites. The incidence of infection at the different
sites was as follows: urinary tract 23%, wound 23%,
lymphocyst 3%, lymphatiso (lymphangitis) 5%,
blood 0%, and bowel (pseudomembranous colitis)
3%.
Seven patients had a preoperative UTI at the
time of admission. Organisms responsible were
Escherichia coli in 4 patients, [3-hemolytic strepto-
coccus group C in patient, Pseudomonas aeruginosa
in patient, and coagulase-negative staphylococcus
in patient. One patient with preoperative UTI
with E. coli developed a postoperative UTI with P.
aeruginosa. None of the other 6 patients had postop-
erative UTI.
Although we are unaware of the exact criteria
used by the individual attending physicians to make
the diagnosis ofwound infection, using our defini-
tion we were retrospectively unable to identify any
patients that went undiagnosed. There was evidence
TABLE 2. Radical vulvectomy with inguinal
lymphadenectomy, same incision vs. separate
groin incisions
Separate Same
incisions incision
No. infected 8 7
No. noninfected 30 2
Total 38 9 (P < 0.05)
aFive of these patients developed wound infections; 2 developed lym-
phangitis.
oferythema, induration, and tenderness of the inci-
sion margin in virtually all of these patients. It is
more difficult to ascertain the incidence of purulent
drainage from the wounds, since drainage was fre-
quently mentioned but not well characterized. Two
cases of wound abscess located in groin incisions
were well documented.
Patients undergoing radical vulvectomy had a
7% incidence of wound infection, while those un-
dergoing concurrent inguinal lymph node dissec-
tion had an incidence of28% (P < 0.05). Of note,
patients undergoing radical vulvectomy with in-
guinal lymphadenectomy had significantly lower
wound infections if separate incisions were used
(Table 2). No difference in the incidence of UTI
was noted in patients undergoing radival vulvec-
tomy with or without inguinal lymph node dissec-
tion (P > 0.05).
The most common urinary pathogen isolated was
P. aeruginosa. A complete list of organisms isolated
from urine postoperatively is given in Table 3. The
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TABLE 3. Pathogens isolated from urine
No. instances No. instances
Pathogen isolated isolated alone
Pseudomonas aeruginosa 5 4
Escherichia coli 5
Enterococcus 3 3
Staphylococcus aureus 0
Enterobacter cloacae 0
Proteus rnirabilis
Candida albicans
TABLE 4. Pathogens isolated from wounds
No. instances No. instances
Pathogen isolated isolated alone
Enterococcus 6 0
Escherichia coli 3
Staphylococcus aureus 0
Pseudornonas aeruginosa 2 0
Enterobacter cloacae 2 0
13-hemolytic streptococcus group G
c-hemolytic streptococcus 2
Klebsiella oxytoca 0
Bacteroides uniforrnis 0
Proteus rnirabilis 0
Klebsiella pneurnoniae 0
Bacteroides species 0
Actinobacter calcoaceticus 0
Streptococcus viridans 0
Peptostreptococcus prevotti 0
Peptostreptococcus anaerobus 0
Eubacteriurn species 0
mean number of urethral catheter insertions per
admission was 1.3 in both urinary-infected and
noninfected patients. The mean duration of ure-
thral drainage was 8.7 days in the infected group
vs. 3.9 days in the noninfected group (P < 0.05).
Wound infections tended to be polymicrobial.
As can be seen from Table 4, the most common
organism isolated from infected wounds was en-
terococcus. The mean duration of Jackson-Pratt
drainage in the wound infected vs. noninfected
group was 9.9 and 9.5 days, respectively
(P > 0.05). The amount of output per drain was
not consistently retrievable from the charts.
C. difficile was isolated from the stool of 2 pa-
tients with diarrhea. One of these patients received
only dose of cefoxitin preoperatively while the
other received 3 days of ampicillin and gentamicin.
The 1st patient had also received trimethoprin-
sulfamethoxazole the week prior to surgery for a
presumed UTI.
The mean number of days to onset of postopera-
tive infection for wound, urine, lymphatics, lym-
phocyst, and bowel were 11, 8, 57, 48, and 5,
respectively.
The most common prophylactic antibiotic used
was cefoxitin. It was used by itself in 22 cases and
parenterally in combination with intraoperative
cephalothin or cefazolin-irrigating solution in 8
cases. Other prophylactic antibiotics used alone or
in combination included cefotetan, flagyl, tri-
methoprin-sulfamethoxazole, ampicillin, gentami-
cin, doxycycline, tetracycline, and erythromycin.
Six patients did not receive any prophylactic antibi-
otic. Two of the patients had postoperative infec-
tions. E. coli was isolated from the urine of
patient while the other subsequently developed lym-
phangitis. Prophylatic antibiotic was administered
from to 3 days perioperatively. Due to the wide
variation in the type, dosage, and duration of pro-
phylactic antibiotic administered, the optimal type
and length of prophylactic antibiotic use could not
be determined.
One patient with advanced-stage vulvar cancer
and no clinical evidence of infection had aerobic
and anaerobic cultures of the necrotic tumor sent
before surgery. Organisms recovered included P.
aeruginosa, ]3-hemolytic streptococcus group B,
anaerobic diptheroids, and anaerobic gram-nega-
tive cocci.
No organisms were isolated in the patients with
lymphangitis, but 2 of 3 patients with this diagno-
sis had associated febrile morbidity. Drainage from
infected lymphocyst grew Klebsiella pneumoniae
and that from another grew Staphylococcus aureus.
Both patients with infected lymphocysts had associ-
ated fevers.
DISCUSSION
To our knowledge, this is the first report looking
specifically at infectious morbidity in patients un-
dergoing radical vulvectomy. Three important ob-
servations were made in this study.
The first finding is the prolonged period oftime
until onset of infection. Whereas wound infection
following hysterectomy or cesarean section tends to
be within 7 days,
2s-28 wound infection following
radical vulvectomy averages 11 days. This rela-
tively late onset of wound infection is surprising
and makes us wonder if factors other than micro-
bial contamination at the time of surgery might be
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the etiologic source. Perhaps presurgical transloca-
tion of bacteria from infected necrotic tumor sites
or altered vaginal flora to regional lymph nodes is
responsible for the late onset of post-surgical infec-
tions, where the lymph node channels are damaged
and isolated. If presurgical translocation of bacteria
does occur in vulvar cancer patients, should peri-
operative antibiotics be considered treatment rather
than prophylaxis? Further studies to determine for
which patients this might be a reasonable assump-
tion remain to be done.
Second, the finding of a decreased incidence of
wound infection following inguinal lymph node
dissection when separate incisions were made com-
plements previous work that has shown a decrease
in the incidence of wound breakdown in these pa-
tients.
29 In addition, the sequence and time course
of appearance of clinical infections following radi-
cal vulvectomy have been documented.
Finally, it is possible that, in large tumors, host
immunity is decreased and musocal barriers are
breached to a greater extent. It is important to
determine if tumor stage and type increase the in-
fectious morbidity of radical vulvar surgery. In
this study, the frequency of wound infections was
not directly related to tumor type or stage, but
tended to increase only if inguinal lymph nodes
were concomitantly removed. For example, if con-
current inguinal lymphadenectomy was performed,
the incidence of wound infection was the same for
stage I and stage III disease. Although the fre-
quency of infection was evaluated in this investiga-
tion, the severity of infection was more difficult to
quantify and compare. Importantly, no deaths from
postoperative infections were found in this series.
Infectious morbidity associated with radical vul-
vectomy is an important clinical problem that de-
serves further investigation. Studies are difficult to
execute by individuals, however, secondary to slow
patient accrual and a wide variation in the surgical
techniques employed. We hope that this work will
stimulate interest among investigators so that pro-
spective cooperative research will be forthcoming.
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